Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gift of Life Donor Program is U.S. Leader in Saving Lives 2019-01-05 01:09
Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administration 2019-01-05 01:04
China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering 2019-01-04 20:30
Alphamab Oncology is Invited to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-04 17:02
Gathering Quality Pharmaceutical Excipients from Around the World, PharmaExcipients China 2019 Helps the Chinese Pharmaceutical Industry Achieve Comprehensive Upgrading 2019-01-04 15:00
Picosun and Nanexa Solidify Their Collaboration in Pharmaceutical ALD 2019-01-04 11:13
Ping An Good Doctor Launches Commercial Operation of One-minute Clinics and Signs Contracts For Nearly 1,000 Units, Serving More Than 3 Million Users 2019-01-04 09:40
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology 2019-01-04 09:30
Charkit Chemical Garners NACD Responsible Distribution Verification For Its Sixth Three-Year Cycle 2019-01-04 07:32
Clarivate Analytics Launches Advanced Predictive Analytics Solution to Help Accelerate Drug Development 2019-01-04 02:04
Dr. Jan M. Lundberg, Former Head of R&D at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors 2019-01-03 17:49
ProBioGen's GlymaxX(R) ADCC Enhancement Technology Used by Betta Pharmaceuticals 2019-01-03 17:22
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2019-01-03 16:00
Gathering Hotspots of the Preparation Industry, In Step with the International Pharmaceutical Trends 2019-01-03 15:00
Sinovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-03 09:00
Ascletis' IND Filing for Its Third HCV Drug ASC21 Accepted by NMPA 2019-01-03 08:00
Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators 2019-01-03 03:15
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
1 837 838 839 840 841 1506